February 13, 2025 — IOI Corporation Berhad (IOI), through our German subsidiary KetoLipix Therapeutics GmbH (KetoLipix), is leading pharmaceutical innovation by developing drug therapies for conditions with high unmet medical need, leveraging KetoLipix’s breakthrough ketone ester technology.

You might also be interested in reading A range-break from Bitcoin could trigger buying in ADA, ATOM, FIL and EOS this week.